All supplements

Supplement evidence

082 / 575Digestive support

Lactase enzyme

View my plan

The short answer

Taken with lactose-containing food, lactase reduces lactose-malabsorption symptoms in many people.

Evidence and scope
Established for an indicated use

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
The benefit is tied to the stated indication, dose, and population; it is not evidence of broader disease prevention or longer life.
Before deciding
Key concern: Does not treat milk-protein allergy; persistent symptoms need evaluation.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective
Meal-specific digestionUse the product dose immediately before or with lactose; dose follows lactose load

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFat/water classification is not the key factor

Fat/water solubility is not the useful decision point; preparation, fluid, timing, or strain identity matters more.

How it is commonly taken

Take with the first bite or add compatible drops to dairy.

Do not combine casually

Does not treat milk-protein allergy; persistent symptoms need evaluation.

Dose and use source

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

2research papers in this ledger
2unique primary studies represented
71unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2020
Supports a specific usePMID 33490624

Effect of lactase on symptoms and hydrogen breath levels in lactose intolerance

Symptoms and breath hydrogen improved with lactase, with cumulative hydrogen about 55% lower than placebo. This was an acute laboratory challenge, not evidence about long-term dairy tolerance or nutrition.

Study design and methods
Design
Randomized, double-blind, placebo-controlled crossover trial
Population
47 adults with breath-test-confirmed lactose intolerance
Intervention
Chewable lactase tablets versus placebo with a lactose challenge
Outcome
Gastrointestinal symptoms and breath hydrogen over 180 minutes
Open research record
1992
Supports a specific usePMID 1534729

Effect of a single dose of lactase after lactose challenge

Lactase reduced breath hydrogen and cramping, belching, flatulence, diarrhea, and later bloating, but did not change plasma glucose. The unusually large 50 g lactose challenge limits everyday dose interpretation.

Study design and methods
Design
Randomized, double-blind, placebo-controlled crossover trial
Population
24 adults with challenge-confirmed lactose malabsorption who completed the study
Intervention
Chewable lactase 9,900 FCC units or placebo with a 50 g lactose challenge
Outcome
Breath hydrogen, glucose absorption, and symptoms

Funding or conflict note: The first author was affiliated with a clinical-research company; the abstract did not report funding.

Open research record
Unscreened discovery appendix—not evidence92 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. Evaluation of in vitro fermentation characteristics and tolerance of lactose-free milk powder for lactose intolerant subjects.Xiong S, Xu W, Si J et al. · 2026 · Food & function · PMID 42186748Open on PubMed
  2. Comparative effects of conventional cow's milk versus milk free of A1-type beta-casein on gastrointestinal physiology and symptoms of digestive discomfort in participants intolerant to conventional cow's milk: a pilot randomised controlled trial.Greenway FL, Hsia DS, Rebello CJ · 2026 · Nutrition journal · PMID 41634798Open on PubMed
  3. Tolerance of protein-hydrolyzed lactose-free A1 milk and A2 milk in lactose-tolerant and lactose-intolerant volunteers: A randomized crossover trial with 2 parallel groups.Mannila E, Hokkanen L, Ahonen E et al. · 2025 · Journal of dairy science · PMID 40614809Open on PubMed
  4. Lactase-Treated A2 Milk as a Feasible Conventional Milk Alternative: Results of a Randomized Controlled Crossover Trial to Assess Tolerance, Gastrointestinal Distress, and Preference for Milks Varying in Casein Types and Lactose Content.Robinson LA, Cavanah AM, Lennon S et al. · 2025 · Nutrients · PMID 40573057Open on PubMed
  5. Effect of lactase supplementation on infant colic: Systematic review of randomized controlled trials.Kozłowska-Jalowska A, Stróżyk A, Horvath A et al. · 2024 · Journal of pediatric gastroenterology and nutrition · PMID 38426798Open on PubMed
  6. Development of a novel SNP assay to detect lactase persistence associated genetic variants.De Luca P, Iaconis D, Biffali E et al. · 2021 · Molecular biology reports · PMID 34515921Open on PubMed
  7. [Efficacy and safety of lactase additive in preterm infants with lactose intolerance: a prospective randomized controlled trial].Wang L, Wang YW, Tan JT et al. · 2021 · Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · PMID 34266522Open on PubMed
  8. A double-blind, 377-subject randomized study identifies Ruminococcus, Coprococcus, Christensenella, and Collinsella as long-term potential key players in the modulation of the gut microbiome of lactose intolerant individuals by galacto-oligosaccharides.Azcarate-Peril MA, Roach J, Marsh A et al. · 2021 · Gut microbes · PMID 34365905Open on PubMed
  9. Treatment efficacy of a low FODMAP diet compared to a low lactose diet in IBS patients: A randomized, cross-over designed study.Krieger-Grübel C, Hutter S, Hiestand M et al. · 2020 · Clinical nutrition ESPEN · PMID 33183577Open on PubMed
  10. Evaluation of breath, plasma, and urinary markers of lactose malabsorption to diagnose lactase non-persistence following lactose or milk ingestion.Shrestha A, Barnett MPG, Perry JK et al. · 2020 · BMC gastroenterology · PMID 32600320Open on PubMed
  11. Effects of Prebiotic and Probiotic Supplementation on Lactase Deficiency and Lactose Intolerance: A Systematic Review of Controlled Trials.Leis R, de Castro MJ, de Lamas C et al. · 2020 · Nutrients · PMID 32443748Open on PubMed
  12. Galacto-Oligosaccharide RP-G28 Improves Multiple Clinical Outcomes in Lactose-Intolerant Patients.Chey W, Sandborn W, Ritter AJ et al. · 2020 · Nutrients · PMID 32290344Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.